
Red Queen Bio identifies and anticipates AI-enabled biological threats and pre-builds medical countermeasures to reduce response time and risk. The company applies AI, including reinforcement learning, defensive compute, and lab automation to model threats and design countermeasure candidates. It operates as a B2B SaaS platform that collaborates directly with frontier labs, governments, biopharma, and AI labs. As a Public Benefit Corporation, Red Queen Bio also engages policymakers and industry partners to encourage incentives and broader collaboration across biodefense.

Red Queen Bio identifies and anticipates AI-enabled biological threats and pre-builds medical countermeasures to reduce response time and risk. The company applies AI, including reinforcement learning, defensive compute, and lab automation to model threats and design countermeasure candidates. It operates as a B2B SaaS platform that collaborates directly with frontier labs, governments, biopharma, and AI labs. As a Public Benefit Corporation, Red Queen Bio also engages policymakers and industry partners to encourage incentives and broader collaboration across biodefense.